ESR1 and breast carcinoma: Consistent with published literature [4, 38], we observed higher proliferation scores in ER- than ER+ samples within both FFPE and fresh tissue (Additional file 3: Figure S3a), confirming the utility of RNA-seq from archival FFPE breast cancer samples in these clinically relevant gene panels.